Log in
Enquire now
‌

US Patent 9474722 Compositions and methods for transdermal delivery of amphetamine

Patent 9474722 was granted and assigned to Noven Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Noven Pharmaceuticals
Noven Pharmaceuticals
Current Assignee
Noven Pharmaceuticals
Noven Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9474722
Patent Inventor Names
Robert L. Lambert0
Date of Patent
October 25, 2016
Patent Application Number
14062360
Date Filed
October 24, 2013
Patent Citations Received
‌
US Patent 11976026 Amphetamine carbamate compounds and methods
0
Patent Primary Examiner
‌
Robert A Wax
Patent abstract

Compositions for the transdermal delivery of amphetamine in a flexible, finite form are described. The compositions comprise a polymer matrix that includes amphetamine or a pharmaceutically acceptable salt or prodrug thereof and a backing layer comprising a polyurethane film layer and a polyester film layer, with a polyurethane adhesive disposed therebetween. Related methods also are described. Also described are compositions that exhibit a short onset period and a long duration of therapeutic effect.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9474722 Compositions and methods for transdermal delivery of amphetamine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us